In several countries in Europe, eConsent is still not possible in its full remote format due to local- and country-specific regulatory and geographic factors. To adapt to the changing times in an effective manner, without compromise to process and efficiency, a flexible approach to implementing eConsent in global studies is essential.
During COVID-19, eConsent was a must-have to enable participant consent and enrollment remotely but how does eConsent fit into the post-COVID world? The benefits of a digitally-enabled consent management process reach far beyond remote or virtual-only trials, from increasing participant access to reducing the number of quality findings. In this webinar, Christina Fawcett (GSK) joins Andrew Mackinnon (Medable) to discuss how to successfully combine agile eConsent technology with global and local regulatory expertise to increase enrollment rates and reduce both site and patient burden.
In this webinar you will learn:
